These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23024775)

  • 1. Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women.
    Hasim A; Abudula M; Aimiduo R; Ma JQ; Jiao Z; Akula G; Wang T; Abudula A
    PLoS One; 2012; 7(9):e44952. PubMed ID: 23024775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
    Sheyhidin I; Hasim A; Zheng F; Ma H
    Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer.
    Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A
    Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of promoter methylation of ERp57 gene with the pathogenesis of cervical lesions in Uighur women].
    Abdula M; Abudulajiang G; Amiduo R; Abudala A; Hasim A
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):600-3. PubMed ID: 24314218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between TAP gene promoter methylation and cervical lesions with HPV infection in Uyghur women].
    Aikuer G; Jiao Z; Wu XC; Ma JQ; Abudla A; Hasim A
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):438-42. PubMed ID: 22932452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
    Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
    Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
    Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
    Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer.
    Seliger B; Stoehr R; Handke D; Mueller A; Ferrone S; Wullich B; Tannapfel A; Hofstaedter F; Hartmann A
    Cancer Immunol Immunother; 2010 Apr; 59(4):529-40. PubMed ID: 19820934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
    Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma.
    Ritter C; Fan K; Paschen A; Reker Hardrup S; Ferrone S; Nghiem P; Ugurel S; Schrama D; Becker JC
    Sci Rep; 2017 May; 7(1):2290. PubMed ID: 28536458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between human papillomavirus type 16 infection and human leukocyte antigen class I expression in cervical cancers of Uighur women].
    Ma Q; Hasim A; Abudukadeer A; Yilike X; Wu GZ; Abudula A
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):255-8. PubMed ID: 20654125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas.
    Cathro HP; Smolkin ME; Theodorescu D; Jo VY; Ferrone S; Frierson HF
    Cancer Immunol Immunother; 2010 Mar; 59(3):465-72. PubMed ID: 19756593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.
    Hirata T; Yamamoto H; Taniguchi H; Horiuchi S; Oki M; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Apr; 211(5):516-523. PubMed ID: 17318812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression.
    Liu Q; Hao C; Su P; Shi J
    Scand J Gastroenterol; 2009; 44(8):960-9. PubMed ID: 19492245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
    Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
    Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
    Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
    Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation of antigen processing machinery components and association with cervical carcinoma.
    Mehta AM; Jordanova ES; van Wezel T; Uh HW; Corver WE; Kwappenberg KM; Verduijn W; Kenter GG; van der Burg SH; Fleuren GJ
    Genes Chromosomes Cancer; 2007 Jun; 46(6):577-86. PubMed ID: 17366619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.
    Lazaridou MF; Gonschorek E; Massa C; Friedrich M; Handke D; Mueller A; Jasinski-Bergner S; Dummer R; Koelblinger P; Seliger B
    Oncoimmunology; 2020 Jun; 9(1):1774323. PubMed ID: 32923135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
    Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
    Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.